Rapid-Onset Psychotic Symptoms After Interferon-β-1a Treatment of Multiple Sclerosis

被引：0
|
作者：
Huang, Jing-Syuan [1 ,2 ]
Chang, Chuan-Chia [2 ]
Tai, Yueh-Ming [1 ,2 ]
Huang, Chien-Peng [3 ]
Chen, Shyi-Jou [4 ]
Tzeng, Nian-Sheng [2 ,5 ]
机构：
[1] Triserv Gen Hosp, Natl Def Med Ctr, Beitou Branch, Dept Psychiat, Taipei, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan
[3] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pathol, Taipei, Taiwan
[4] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pediat, Taipei, Taiwan
[5] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2020年 / 27卷 / 06期
关键词：
IFN-BETA-1A; THERAPY; PATIENT;
D O I：
10.1097/MJT.0000000000001017
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：E627 / E629
页数：4
相关论文
共 50 条
  • [31] Subcutaneous Recombinant Interferon-β-1a (Rebif®) A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Sanford, Mark
    Lyseng-Williamson, Katherine A.
    DRUGS, 2011, 71 (14) : 1865 - 1891
  • [32] Subcutaneous Recombinant Interferon-β-1a (Rebif®)A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Mark Sanford
    Katherine A. Lyseng-Williamson
    Drugs, 2011, 71 : 1865 - 1891
  • [33] Erratum: Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment
    M Hecker
    R H Goertsches
    C Fatum
    D Koczan
    H-J Thiesen
    R Guthke
    U K Zettl
    The Pharmacogenomics Journal, 2012, 12 : 360 - 360
  • [34] Interferon-β1b for the treatment of multiple sclerosis
    Lam, Sum
    Wang, Shan
    Gottesman, Malcolm
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1111 - 1117
  • [35] Interferon-β1b in the treatment of multiple sclerosis
    Río, J
    Montalban, X
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2877 - 2886
  • [36] Cost effectiveness of Fingolimod Compared to Interferon-β1a in the Management of Pediatric-Onset Multiple Sclerosis (POMS) in Canada
    Nakhaipour, Hamid Reza
    Vudumula, Umakanth
    Toram, Nagasuman
    Khurana, Vivek
    Schecter, Robyn
    Pohl, Daniela
    Adlard, Nicholas
    NEUROLOGY, 2019, 92 (15)
  • [37] Treatment recommendations for interferon-β in multiple sclerosis
    Polman, CH
    Miller, DH
    McDonald, WI
    Thompson, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (05): : 561 - 564
  • [38] Rapid-Onset Immune Thrombocytopenia Following Alemtuzumab Treatment in Relapsing, Remitting Multiple Sclerosis
    Obermann, Mark
    NEUROLOGY, 2016, 86
  • [39] Interferon-β treatment for relapsing multiple sclerosis
    Weinstock-Guttman, Bianca
    Ramanathan, Murali
    Zivadinov, Robert
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (09) : 1435 - 1447
  • [40] Interferon-β-1a/interferon-β-1bMultiple sclerosis exacerbation: 9 case reports
    Reactions Weekly, 2012, 1394 (1) : 27 - 27
12345